Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Express Scripts
Dow
Teva
Farmers Insurance
Accenture
Harvard Business School
Federal Trade Commission
Fuji

Generated: December 10, 2018

DrugPatentWatch Database Preview

Litigation Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

« Back to Dashboard

Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Docket ➤ Sign Up Date Filed 2014-07-07
Court District Court, D. Delaware Date Terminated 2017-04-25
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ACCORD HEALTHCARE INC.; ACORDA THERAPEUTICS INC. ; ACTAVIS INC.; ACTAVIS LABORATORIES FL INC.; ACTAVIS PHARMA INC.; ALKEM LABORATORIES LTD.; ALKERMES PHARMA IRELAND LIMITED; ANDRX CORPORATION; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; MYLAN PHARMACEUTICALS INC.; ROXANE LABORATORIES INC.; TEVA PHARMACEUTICALS USA INC.; WATSON LABORATORIES INC.
Patents 5,540,938; 8,007,826; 8,354,437; 8,440,703; 8,663,685
Attorneys A. Taylor Corbitt; Aaron Stiefel; Alison L. Maddeford; Brie L.B. Buchanan; Bryce A. Cooper; Cedric C. Y. Tan; Charles B. Klein; Cindy Ahn; Daniel P. DiNapoli; David A. Bilson; Eve H. Ormerod; George C. Lombardi; George Chih-Lun Yu; George J. Barry , III; Grace Yang, Ph.D.; Imron T. Aly; Jack B. Blumenfeld; Jason Pesick; Jeffrey Martin; Jeremy A. Tigan; John C. Phillips , Jr.; Joseph R. Robinson; Karen L. Carroll; Mary Matterer; Maryellen Noreika; Megan C. Haney; Micheal L. Binns; Neal C. Belgam; Nicole R. Sullivan; Reid Smith; Robert L. Florence; Sailesh K. Patel; Samuel S. Park; Sharick Naqi; Soumitra Deka; Steven J. Fineman; Timothy H. Kratz; Yun Wei
Firms Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Smith, Katzenstein, & Jenkins LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Acorda Therapeutics Inc. v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for Acorda Therapeutics Inc. v. Alkem Laboratories Ltd. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-07 1 Actavis for patent infringement of United States Patent Nos. 8,007,826 (the “’826 patent”), 8,354,437…alleging that the ’826 patent, the ’437 patent, the ’703 patent, and the ’685 patent are “invalid, unenforceable…expiration of the ’826 patent, the ’437 patent, the ’703 patent and the ’685 patent.” Case 1:14-cV-00882…8,354,437 (the “’437 patent”), 8,440,703 (the “’703 patent”) and 8,663,685 (the “’685 patent”) (collectively,…for the ’826 patent as May 26, 2027, the ’437 patent as December 22, 2026, the ’703 patent as April 8, External link to document
2016-03-16 195 Orange Book-listed patents: U.S. Patent Nos. 5,540,938 (the '" 938 patent"), 8,007,826 (…quot; 703 patent"), and 8,663, 685 (the '" 685 patent"). The asserted patents relate … (the '" 826 patent"), 8,354,437 (the '"437 patent"), 8,440,703 (the '…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification External link to document
2016-10-28 272 The patents-in-suit are U.S. Patent No. 5,540,938 (’938 Patent) and the Acorda Patents: … U.S. Patent Nos. 8,007,826 (’826 Patent), 8,354,437 (’437 Patent), 8,440,703 (’703 Patent…’685 Patent). The “Asserted Claims” refers to: ’938 Patent claims 3 and 8; ’826 Patent claims…938 Patent and Apr. 9, 2004 for the ’826, ’437, ’703 and ’685 Patents (the Acorda Patents). …7, 38 and 39; ’437 Patent claims 1, 2, 5, 22, 32, 36 and 37; ’703 Patent claims 36, 38 and External link to document
2017-03-31 284 States Patents. Patent No. 5,540,938 (the '"938 patent" or the "Elan Patent")…;). Patent Nos. 8,007,826 (the '"826 patent"), 8,663,685 (the '"685 patent"…prior art to the Elan Patent are also prior art to the Acorda Patents. The Elan Patent itself, which was …the '826 patent; claims 3 and 5 of the '685 patent; claim 22 of the '437 patent; and claims…Acorda Patents. See Merck, 395 F.3d at 1377. Because the Acorda Patents practice the Elan Patent, 43 no External link to document
2017-04-25 289 that claims 3 and 8 of U.S. Patent No. 5,540,938 (the "'938 Patent") would be infringed by…of U.S. Patent No. 8,007,826 (the· "'826 Patent"); claims 3 and 5 of U.S. Patent No. 8,663,685…the '"685 Patent"); claims 1, 2, 5, 22, 32, 36 and 37 of U.S. Patent No. 8,354;437 (the …the "'437 Patent"); and claims 36, 38 and 45 of U.S. Patent No. 8,440,703 (the '"…38 and 39 of the '826 Patent, claims 3 and 5 of the '685 Patent, claims 1, 2, 5, 22, 32, 36 External link to document
2017-05-16 290 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,007,826; 8,354,437; 8,440,703…2014 25 April 2017 1:14-cv-00882 830 Patent None District Court, D. Delaware External link to document
2014-07-07 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,007,826; 8,354,437; 8,440,703…2014 25 April 2017 1:14-cv-00882 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cipla
Cerilliant
QuintilesIMS
Boehringer Ingelheim
Citi
McKesson
Fish and Richardson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.